000 01648 a2200469 4500
005 20250517154733.0
264 0 _c20170914
008 201709s 0 0 eng d
022 _a1464-3405
024 7 _a10.1016/j.bmcl.2017.05.018
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMould, Daniel P
245 0 0 _aDevelopment of 5-hydroxypyrazole derivatives as reversible inhibitors of lysine specific demethylase 1.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_c07 2017
300 _a3190-3195 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aB7-2 Antigen
_xmetabolism
650 0 4 _aBinding Sites
650 0 4 _aCatalytic Domain
650 0 4 _aCell Differentiation
_xdrug effects
650 0 4 _aCell Line
650 0 4 _aHalf-Life
650 0 4 _aHistone Demethylases
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aInhibitory Concentration 50
650 0 4 _aMice
650 0 4 _aMolecular Docking Simulation
650 0 4 _aPyrazoles
_xchemical synthesis
650 0 4 _aStructure-Activity Relationship
650 0 4 _aSurface Plasmon Resonance
700 1 _aBremberg, Ulf
700 1 _aJordan, Allan M
700 1 _aGeitmann, Matthis
700 1 _aMaiques-Diaz, Alba
700 1 _aMcGonagle, Alison E
700 1 _aSmall, Helen F
700 1 _aSomervaille, Tim C P
700 1 _aOgilvie, Donald
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 27
_gno. 14
_gp. 3190-3195
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2017.05.018
_zAvailable from publisher's website
999 _c27211524
_d27211524